| Title | Year Published | Product Code |
| Nonnutritive Sweeteners: Current Use and Health Perspectives | 2012 | --- |
| Creating a 21st Century Global Health Agenda: The General Assembly of the United Nations High Level Meeting on Non-Communicable Diseases | 2011 | --- |
| Triglycerides and Cardiovascular Disease | 2011 | --- |
| ADA/AHA/ACCF Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes | 2010 | KB-0039 |
| Thiazolidinedione Drugs and Cardiovascular Risks | 2010 | KB-0036 |
| Exercise Training for Type 2 Diabetes Mellitus: Impact on Cardiovascular Risk | 2009 | LS-2091 |
| Hyperglycemia and Acute Coronary Syndrome | 2008 | 71-0437 |
| Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus | 2006 | 71-0379 |
| Preventing Cardiovascular Disease and Diabetes: A Call to Action from the American Diabetes Association and the American Heart Association | 2006 | 71-0366 |
Diagnosis and Management of the Metabolic Syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement – Executive Summary | 2005 | 71-0336 |
Diagnosis and Management of the Metabolic Syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement | 2005 | 71-0336 |
| Overweight in Children and Adolescents | 2005 | 71-0320 |
| AHA/NHLBI/ADA Conference Proceedings Clinical Management of Metabolic Syndrome | 2004 | 71-0275 |
| NHLBI/AHA Conference Proceedings: Definition of Metabolic Syndrome | 2004 | 71-0274 |
| Thiazolidinedione Use, Fluid Retention, and Congestive Heart Failure | 2003 | 71-0272 |
| Obesity, Insulin Resistance, Diabetes, and Cardiovascular Risk in Children | 2003 | 71-0251 |
Prevention Conference VI: Diabetes and Cardiovascular Disease: Executive Summary | 2002 | 71-0225 |
| Diabetes and Cardiovascular Disease | 1999 | 71-0175 |